week 46 check-in — 47kg down, the food-noise thing manageable, one thing confusing me
Long-ish post, sorry. tl;dr at the bottom.
I have been tracking retatrutide against ApoB for 29 weeks because I could not find anyone who had. The correlation is weaker than I expected, which is itself mildly interesting given how confidently people link the two in here.
Caveats up front: one person, one lab, one assay, no control, and I changed my training in the middle of it, which was stupid.
tl;dr: probably real, definitely smaller than the threads imply, and not worth reorganising your week around.
best — the order this archive was captured in
Not convinced. The evidence does not support that reading.
triple agonism is dose escalation, do not generalise
TRIUMPH phase 2 showed 98.6% weight loss but the early fullness profile on the highest arm was rough. Phase 2 != phase 3.
the 15mg arm is different from 12.5mg, results do not transfer
the 15mg arm is different from 12.5mg, results do not transfer
Disagree on that part. 97.9% and 97.6% on the same vial is normal.
This is correct. Triple agonism is genuinely different.
Research use material only, no human-use approval anywhere. Posts must describe what happened, not instruct strangers.
triple agonism is phase 2, do not generalise
Slight fix: the number was 98.9, not 99.0. Decimal point, but a fairly consequential one.
[removed by moderator]
triple agonism plus glucagon is a different physiological state than GIP/GLP-1 dual
Strongly agree. Heart rate escalation needs the actual data, not impressions.
the glucagon component changes the side effect profile, not just the efficacy
- 1This is correct. Triple agonism is genuinely different.8 comments in this branch · started by u/emil_wojcik
- 2Not convinced. The evidence does not support that reading.5 comments in this branch · started by u/bilal_osei